LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Corporate  :  Piramal Enterprises inks agreement to acquire Ash Stevens

Piramal Enterprises inks agreement to acquire Ash Stevens (16-Aug-2016)

Piramal Enterprises (PEL) wholly owned subsidiary in the US has entered into an agreement to acquire 100% stake in Ash Stevens Inc., a US based Contract Development and Manufacturing Organisation ('CDMO'), in an all cash deal for a total consideration of $42.95 million plus an earn-out consideration capped at $10 million, subject to achievement of certain EBITDA targets, payable over the next six months. This acquisition adds effective molecule manufacturing capabilities to the portfolio of services offered by PEL's Pharma Solutions business. This potential transaction is expected to be completed by end of August.

Ash Stevens has 12 FDA approvals for innovator small molecule APIs and has a pipeline of development products. The Company primarily operates from a FDA approved commercial manufacturing facility located in Riverview, Michigan, USA. The Riverview Facility has approvals from US, EU, Australia, Japan, Korea, Mexico regulatory agencies.

Piramal Enterprises is an industrial conglomerate company. It operates the businesses of healthcare services, capital management, information management, glass, piramal realty and piramal foundation. It also offers pharma solutions including critical care, imaging, bio-orthopaedics and phytomedicines in healthcare.



Top News Today
Wintac gets nod for slump sale of pharmaceutical business undertaking
(27-Apr-2018)

Wintac gets nod for slump sale of pharmaceutical business undertakingWintac's board has approved the proposal to effect slump sale of the Pharmaceutical Business Undertaking of the company to Par Formulations. The board of directors of the company at their meeting held......click on news to read complete article.

Reliance Capital reports marginal rise in Q4 consolidated net profit
(27-Apr-2018)

Reliance Capital reports marginal rise in Q4 consolidated net profitReliance Capital has reported results for the fourth quarter and year ended March 31, 2018.The company has reported a rise of 36.77% in its net profit at Rs 212 crore for the quarter ended March 31, 2018......click on news to read complete article.

Capital India Finance planning to raise funds
(27-Apr-2018)

Capital India Finance planning to raise fundsCapital India Finance is planning to borrow/ raise funds in Indian/foreign currency by issue of debt securities, including but not limited to non-convertible debentures, bonds, MTN. The meeting of the......click on news to read complete article.

International Stock News
Asian markets trade mostly higher on Friday
(27-Apr-2018)

Asian markets trade mostly higher on FridayAll the Asian markets barring Shanghai Composite are trading in green terrain on Friday as investors' concerns over geopolitical risks eased on looming trade talks between the U.S. and China and the leaders......click on news to read complete article.

US markets closed higher; Dow logs best one-day gain in two weeks
(27-Apr-2018)

US markets closed higher; Dow logs best one-day gain in two weeksThe US markets closed higher on Thursday, with the Dow Jones Industrial Average booked its best one-day gain in about two weeks and the broader market all saw gains of at least 1% on the back of better-than-expected......click on news to read complete article.

Asian markets trade mostly lower in early deals on Thursday
(26-Apr-2018)

Asian markets trade mostly lower in early deals on ThursdayMost of the Asian equity benchmarks are trading lower in the early deals on Thursday, following the lackluster cues overnight from Wall Street. Though, Japan's Nikkei share average rose, buoyed by gains......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.